Literature DB >> 16913829

Yellow fever: a disease that has yet to be conquered.

Alan D T Barrett1, Stephen Higgs.   

Abstract

Yellow fever virus (YFV) is the prototype member of the genus Flavivirus, a group of viruses that are transmitted between vertebrates by arthropod vectors. The virus is found in tropical regions of Africa and South America and is transmitted to primates by mosquitoes: Aedes spp. in Africa and Haemagogus and Sabethes spp. in South America. Despite the availability of an effective vaccine, yellow fever (YF) is considered a reemerging disease owing to its increased incidence in the past 25 years. Molecular epidemiologic data suggest there are seven genotypes of YFV that are geographically separated, and outbreaks of disease are more associated with particular genotypes. In addition, the risk of urban YF, owing to transmission of the virus by Aedes aegypti, is increasing in Africa, as is the potential of urban YF returning to South America. Both present serious potential public health problems to large population centers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16913829     DOI: 10.1146/annurev.ento.52.110405.091454

Source DB:  PubMed          Journal:  Annu Rev Entomol        ISSN: 0066-4170            Impact factor:   19.686


  133 in total

1.  BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.

Authors:  Justin G Julander; Shanta Bantia; Brian R Taubenheim; Dena M Minning; Pravin Kotian; John D Morrey; Donald F Smee; William P Sheridan; Yarlagadda S Babu
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Authors:  Eloise Mastrangelo; Margherita Pezzullo; Tine De Burghgraeve; Suzanne Kaptein; Boris Pastorino; Kai Dallmeier; Xavier de Lamballerie; Johan Neyts; Alicia M Hanson; David N Frick; Martino Bolognesi; Mario Milani
Journal:  J Antimicrob Chemother       Date:  2012-04-25       Impact factor: 5.790

3.  Flavitrack: an annotated database of flavivirus sequences.

Authors:  Milind Misra; Catherine H Schein
Journal:  Bioinformatics       Date:  2007-07-28       Impact factor: 6.937

4.  SAAG-4 is a novel mosquito salivary protein that programmes host CD4 T cells to express IL-4.

Authors:  V D Boppana; S Thangamani; A J Adler; S K Wikel
Journal:  Parasite Immunol       Date:  2009-06       Impact factor: 2.280

5.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 6.  Consequences of congenital Zika virus infection.

Authors:  Derek J Platt; Jonathan J Miner
Journal:  Curr Opin Virol       Date:  2017-11-06       Impact factor: 7.090

Review 7.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

8.  Cloning and characterization of ribosomal protein S29, a deltamethrin resistance associated gene from Culex pipiens pallens.

Authors:  Haibo Sun; Linchun Sun; Ji He; Bo Shen; Jing Yu; Chen Chen; Mifang Yang; Yan Sun; Donghui Zhang; Lei Ma; Changliang Zhu
Journal:  Parasitol Res       Date:  2011-05-12       Impact factor: 2.289

9.  Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

Authors:  Eddie A James; Rebecca E LaFond; Theresa J Gates; Duy T Mai; Uma Malhotra; William W Kwok
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

10.  Ontology for vector surveillance and management.

Authors:  Saul Lozano-Fuentes; Aritra Bandyopadhyay; Lindsay G Cowell; Albert Goldfain; Lars Eisen
Journal:  J Med Entomol       Date:  2013-01       Impact factor: 2.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.